StackStone Wealth’s United Therapeutics UTHR Stock Holding History

StackStone Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.45M	Buy	+4,515	New	+$2.33M	0.24%	118

Other funds holding UTHR

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

StackStone Wealth's UTHR Position: Q3 2026 in Review

StackStone Wealth opened a new position in United Therapeutics (UTHR) in Q3 2026: 4,515 shares worth $2.45M. The stake represents 0.24% of the portfolio and ranks #118 among its holdings.

241 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

StackStone Wealth held 4,515 shares of United Therapeutics worth $2.45M as of Q3 2026.
United Therapeutics was a new StackStone Wealth position in Q3 2026.
United Therapeutics made up 0.24% of StackStone Wealth's portfolio in Q3 2026, its #118 holding.
241 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on StackStone Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.